GE HealthCare Invests $945M to Strengthen Imaging Drug Business
GE HealthCare has committed to bolstering its fast-growing imaging drug business with a significant investment of $945 million. Crain's Chicago Business reports on this strategic move.
GE HealthCare has committed to bolstering its fast-growing imaging drug business with a significant investment of $945 million. Crain's Chicago Business reports on this strategic move.